Corify Care
Financials
Estimates*
EUR | 2019 | 2020 | 2021 |
---|---|---|---|
Revenues | <1m | <1m | <1m |
% growth | - | 3 % | 769 % |
EBITDA | <1m | <1m | (<1m) |
% EBITDA margin | 10 % | 157 % | (14 %) |
Profit | <1m | <1m | <1m |
% profit margin | 3 % | 109 % | 614 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€70.0k | Grant | ||
N/A | €300k | Seed | |
N/A | Spinout | ||
* | €1.0m | Grant | |
€600k | Seed | ||
€400k | Support Program | ||
€2.4m | Seed | ||
Total Funding | CAD7.1m |
Related Content
Recent News about Corify Care
EditCorify Care S.L. (Corify) is a medical technology startup that operates in the healthcare sector, specifically focusing on cardiac care. The company's primary mission is to improve the clinical management of cardiac arrhythmias, a heart condition that affects over 60 million patients globally. This number is projected to double in the coming decades.
Corify's flagship product is the ACORYS MAPPING SYSTEM, a groundbreaking medical device that allows healthcare professionals to non-invasively visualize the electrical activity on the surface of the heart. This innovative system eliminates the need for invasive procedures like catheterization or MRI/CT imaging, making it a safer and more comfortable option for patients.
The ACORYS MAPPING SYSTEM aims to increase the treatment success ratio for cardiac arrhythmias, which is currently low despite the availability of multiple diagnostic techniques and therapeutic options. By providing a more detailed and accurate view of the heart's electrical activity, the system enables clinicians to tailor treatment strategies to each patient's unique needs, thereby enhancing the effectiveness of the treatment.
Corify's business model revolves around the development, production, and sale of the ACORYS MAPPING SYSTEM to healthcare providers. The company generates revenue through the sale of these devices and potentially through ongoing service and maintenance contracts.
Keywords: Medical Technology, Cardiac Care, Cardiac Arrhythmias, Non-Invasive Diagnosis, ACORYS MAPPING SYSTEM, Personalized Treatment, Healthcare Providers, Clinical Management, Medical Device Development, Revenue Generation.